SlideShare a Scribd company logo
1 of 34
A. Panagopoulos & Park 2013 1
Patents v. Trade Secrets
In-Uck Park
Andreas Panagopoulos
Panagopoulos & Park 2013 2
Objective
• Are patents better than TS and in what
context?
• This is important because recent
theoretical evidence points to TS being
conducive to tech transfer; see Anton and
Yao 1993, and Henry and Ponce 2011
(both relying on a free riding threat).
We argue that
• patents have forward looking effects that
TS lack
• because they, can be used as bargaining
chips in future tech transferring
negotiations.
• when patent rights are fully transferred
they should merit a markup over TS.
Panagopoulos & Park 2013 3
In detail
• It is understood that patent portfolios
endow firms with the legal power needed
in gaining a better hand in out of court
settlement negotiations. In this respect, a
transfer of patent rights that increases the
size of a patent portfolio serves a dual
purpose.
Panagopoulos & Park 2013 4
Dual purpose
• A) It expands the firm’s tech-horizon,
• B) It increases its legal gravity when
bargaining an out of court settlement.
• This suggests that a patent does not only
convey monopoly profits on the technology
embodied in the patent (as TS do), it also
conveys pecuniary benefits that are related to
the ability of a patent to be used as a
bargaining chip for future licensing
negotiations (markup).Panagopoulos & Park 2013 5
Forms of tech transfer
• From all different forms of tech transfer,
such as licensing, the formation of a
patent pool, patent donations, the sale of
patents, or a firm takeover, only the last
two imply a full transfer of patent rights
that can merit such a markup.
Panagopoulos & Park 2013 6
Problem
• Easy to argue, hard to prove because this
argument implies that patents can capture
rents from future deals. Hence the
argument is recursive and if, at any point
in a series of tech transferring
agreements, a patent fails to capture
sufficient rents (as to stimulate a patent
generating innovation) the argument
collapses.
Panagopoulos & Park 2013 7
Startups
• We argue our case for a subset of all firms
(albeit a very important one) startups.
• This is because a) startup firms rely on
tech transfer and b) they lack the funds
and legal power to avoid being coerced
into a deal by an incumbent who holds a
patent portfolio and alleges infringement,
and c) a series of startup buyouts is now a
familiar occurrence (OI).
Panagopoulos & Park 2013 8
Asymmetries
• In strengthening our argument, we argue
our case in the most favorable scenario for
TS i.e. TS fully avoid disclosing the
technology at hand. Hence TS cannot
invite infringement proceedings, patents
can.
• i.e. two asymmetries: startups are different
than incumbents; TS avoid disclosure,
while patents don’t.
Panagopoulos & Park 2013 9
The model
• We analyze a model in which an
incumbent who owns a patent portfolio
negotiates (via Nash bargaining) a
takeover agreement with a sequence of
startups. With each takeover the patent
portfolio of the incumbent increases,
increasing i) her ability to threaten future
startups with infringement proceedings
and ii) her bargaining power in future
takeover negotiations.
Panagopoulos & Park 2013 10
Results:
• We find that as long as IP protection is
moderate patents can motivate R&D
efforts that would not have taken place
otherwise. If IP protection is balanced
startups should prefer TS
Panagopoulos & Park 2013 11
Panagopoulos & Park 2013 12
Why balanced?
• If IP protection is limited entrants abstain from
innovating; because their innovation is not
adequately protected from the incumbent.
• The same holds true if IP protection is very
strong.
• If IP protection is moderate, the incumbent’s
benefits of a takeover go beyond
commercializing the new innovation.
Panagopoulos & Park 2013 13
A static model
• Firm 1 is the dominant firm, and 2 is the startup.
• Firm 2 can do R&D at a cost C>0.
• The value of the innovation is V>0 if 2 commercialises it,
and if firm 1 does as well (Note: is not the
driving force behind our results)
• Innovation is sequential; potential infringement.
• If the case ends in court 2 loses with probability p.
• No litigation cost.
VV
*
VV
*
Panagopoulos & Park 2013 14
• The disagreement/threat points of the firm are the
respective expected surpluses from litigation.
2211
,
*
2121
*
2
*
1
21
max
:Hence
,
:asdefinedissetbargainingNashthe
gy,technolotheofvaluemaximumtheisSince
1and
dsds
VssssB
V
VpdpVd
Bss
Panagopoulos & Park 2013 15
• Stronger IP protection (a greater p) decreases the share
of 2 via weakening its bargaining position, reducing her
incentives to innovate.
• Note: this is also a licensing solution.
• A takeover/licensing is always preferable to litigation.
1,0/
2
11
)(
2
11
)(
*
*
2
*
1
VVr
V
rrp
ps
V
rrp
ps
For TS
Panagopoulos & Park 2013 16
Vdd 21
and0
2
2
*
2
*
1
VV
s
VV
s
For the static model
Since we have a one off Nash bargaining
negotiation and there are no future benefits for
patents: TS is better than patents because they
do not invite infringement allegations.
Panagopoulos & Park 2013 17
Panagopoulos & Park 2013 18
A sequential model
• With a positive level of IP protection the value of owning
the PATENTED innovation to firm 1 is V* plus the
increment in future bargaining share due to strengthening
its bargaining position via enlarging its portfolio.
• Therefore the surplus of firm 2 may be larger than in the
static model.
• To capture this we model probability p as a function of the
number of patents in the incumbent’s portfolio t (where t
also denotes time periods), and the level of IP protection
z.
∂p/∂z>0, ∂p/∂t>0, ∂²p/∂t²<0
Panagopoulos & Park 2013 19
• Patented innovation should stop when
• What matters here though is if innovation via
patents is possible when the cost of innovation
is at least equal to the innovator’s payoff when
the innovation is protected via a TS.
• To display our point C is at least equal to 2’s
maximum payoff from keeping the innovation
as a TS. Hence, after this point is reached a TS
prevails i.e. firms prefer the static solution.
• We label the last period a startup innovates and
patents as T.
Cts2
• Nonetheless, not all startups are created
as equal.
• Some have an R&D cost above C, some
not (skewed distribution).
• We assume that is the probability that
the R&D cost is zero, and (1- ) that it is
greater or equal to C.
Panagopoulos & Park 2013 20
Panagopoulos & Park 2013 21
Notation
• X(t): the value of the incumbent from deals
surrounding innovations not yet realised, at the
beginning of a period with portfolio t
• s1 and s2 the bargaining shares, from Nash
bargaining, of the two firms (incumbent and
entrant).
• discount rate
• If the case is litigated the incumbent wins with
probability p(z), where z denotes IP protection.
Panagopoulos & Park 2013 22
The model
• On the last date T that there is a patented
innovation:
• NOTE: the hat above a variable denotes t<=T
(1),)1()(ˆ)(ˆ
1
TXTsTX
Panagopoulos & Park 2013 23
• On the first date that there is no innovation by
a high cost firm:
(2),)1()()(1)( 1
tXtstXtX
Panagopoulos & Park 2013 24
)()1(
*
tXtXV
VtpdVtpd zz
)(1,)( 2
*
1
The total surplus that the innovation can generate
to the two firms is maximised when firm 1
commercialises it and adds it to its patent portfolio.
In this case the total surplus is:
The threat points are
Panagopoulos & Park 2013 25
The bargaining shares
• Which can be plugged into eq. (2) to get a difference
equation that describes X(1), X(2)….etc.
• Note: s1 & s2 are strictly greater than the static licensing
solution.
2
1
2
11
2
1
2
11
*
2
*
1
tXtX
V
rrtp
ts
tXtX
V
rrtp
ts
z
z
Panagopoulos & Park 2013 26
The difference equation
*
3
11
3
12
1 V
rrtp
tXtXtX z
Proposition: The above sequence {X(t)} is unique,
monotonically increases at a decreasing rate, i.e., X(t)-X(t-
1)>X(t+1)-X(t)>0 for all t>1, and converges to
*
12
11
V
rrp
X z
Proposition: in any equilibrium there exists T<∞ such that a
startup does not innovate and patent in any period t>T.
Panagopoulos & Park 2013 27
Before reaching T
)(ˆ)1(
*
tXtXV
VtpdVtpd zz
)(1,)( 2
*
1
The total surplus that the innovation can generate
to the two firms is maximised when firm 1
commercialises it and adds it to its patent portfolio.
In this case the total surplus is:
The threat points are
TsTs
tXtX
V
rrtp
ts
tXtX
V
rrtp
ts
z
z
22
*
2
*
1
ˆ
2
ˆ1
2
11
ˆ
2
ˆ1
2
11
ˆ
Panagopoulos & Park 2013 28
TsCTs
TsTs
22
22
ˆthatpossibleisit
ˆAs
We solve this problem through the use of
mixed strategies.
We show that there exists a unique value α∈(0,1-η),
for which an equilibrium solution is possible.
Panagopoulos & Park 2013 29
Theorem
• Up to T high cost startups prefer patents after
that startups are indifferent to patents or TS (TS
prevails).
• A similar argument is proved for low cost
startups.
• The argument does not collapse because:
• Patent length
• Patent donations
Panagopoulos & Park 2013 30
Simulation
We initially simulate for δ=.97 and η=.2 and then for δ=.99 and η=.8.
To provide an example (in line with the magnitudes of z we find):
when z=.007 a firm with a portfolio made up of 100 patents stands
a 50% chance of winning its case, and an increase of 1 patent raises
this by .34%.
We argue our case for V*=1, r=1, and C=1.0001.
An r=1 allows for results that are not driven by the disparity between V and V*,
Additionally, by choosing C>1 we ensure that:
a) innovation by high-cost startups may only be possible in a dynamic model
b) that IP protection is necessary for such innovation because
pz(t) is constant at 0 for all t if z=0, erasing any dynamic effect.
t
z
ztp 11)(
Panagopoulos & Park 2013 31
Converging s2
Panagopoulos & Park 2013 32
Inverse U
• To examine how z affects T, we find the values of T for
z's between .0001 and .01 in 20 steps of .0005.
Panagopoulos & Park 2013 33
Varying δ
Panagopoulos & Park 2013 34
Varying η

More Related Content

Similar to Epip 2013

Client advisory faq patents - 2011
Client advisory   faq patents - 2011Client advisory   faq patents - 2011
Client advisory faq patents - 2011MMMTechLaw
 
Patent Quality Isn't the Question. Patent Value Is the Question.
Patent Quality Isn't the Question. Patent Value Is the Question.Patent Quality Isn't the Question. Patent Value Is the Question.
Patent Quality Isn't the Question. Patent Value Is the Question.Erik Oliver
 
Methods to improve Freedom to Operate analysis
Methods to improve Freedom to Operate analysisMethods to improve Freedom to Operate analysis
Methods to improve Freedom to Operate analysisDauverC
 
Patent hold up and the antitrustization of frand - A multi-sided reappraisal ...
Patent hold up and the antitrustization of frand - A multi-sided reappraisal ...Patent hold up and the antitrustization of frand - A multi-sided reappraisal ...
Patent hold up and the antitrustization of frand - A multi-sided reappraisal ...Nicolas Petit
 
What every Tech Startup should know about Intellectual Property
What every Tech Startup should know about Intellectual PropertyWhat every Tech Startup should know about Intellectual Property
What every Tech Startup should know about Intellectual PropertyHerve Flutto
 
Understanding the Financial Value of Your Patent Portfolio: A Practical Guide...
Understanding the Financial Value of Your Patent Portfolio: A Practical Guide...Understanding the Financial Value of Your Patent Portfolio: A Practical Guide...
Understanding the Financial Value of Your Patent Portfolio: A Practical Guide...Foresight Valuation Group
 
You Need Defensive Patents but You Don't Have Any. Now What? A Case Study
You Need Defensive Patents but You Don't Have Any. Now What? A Case StudyYou Need Defensive Patents but You Don't Have Any. Now What? A Case Study
You Need Defensive Patents but You Don't Have Any. Now What? A Case StudyErik Oliver
 
Bidding the Inventions as Incentive Schemes and the Ownership Structure
Bidding the Inventions as Incentive Schemes and the Ownership StructureBidding the Inventions as Incentive Schemes and the Ownership Structure
Bidding the Inventions as Incentive Schemes and the Ownership StructurePalkansaajien tutkimuslaitos
 
Patent Portfolio Development and Use
Patent Portfolio Development and UsePatent Portfolio Development and Use
Patent Portfolio Development and UseKristina Mcdonough
 
mHealth Israel_Patent Strategy: Disruptive vs Incremental Innovation
mHealth Israel_Patent Strategy: Disruptive vs  Incremental InnovationmHealth Israel_Patent Strategy: Disruptive vs  Incremental Innovation
mHealth Israel_Patent Strategy: Disruptive vs Incremental InnovationLevi Shapiro
 
IP presentation_impact_hub_final-22
IP presentation_impact_hub_final-22IP presentation_impact_hub_final-22
IP presentation_impact_hub_final-22Anja Mihaldinec
 
Management Of Technology(Ravish Roshan,9968009808)
Management Of Technology(Ravish Roshan,9968009808)Management Of Technology(Ravish Roshan,9968009808)
Management Of Technology(Ravish Roshan,9968009808)Ravish Roshan
 
Profiting from technological innovation
Profiting from technological innovationProfiting from technological innovation
Profiting from technological innovationAmirSalimi11
 
Patent Strategy for Startups, Hardware Workshop SF 2015
Patent Strategy for Startups, Hardware Workshop SF 2015 Patent Strategy for Startups, Hardware Workshop SF 2015
Patent Strategy for Startups, Hardware Workshop SF 2015 Peter Miller
 
Standard Essential Patents Licensing Royalty Disputes 4Q 2013
Standard Essential Patents Licensing Royalty Disputes 4Q 2013Standard Essential Patents Licensing Royalty Disputes 4Q 2013
Standard Essential Patents Licensing Royalty Disputes 4Q 2013Alex G. Lee, Ph.D. Esq. CLP
 
How to choose between patents or trade secrets.pdf
How to choose between patents or trade secrets.pdfHow to choose between patents or trade secrets.pdf
How to choose between patents or trade secrets.pdfBoolean IP Consulting
 
4-28-16 IP for general counsel (publish)
4-28-16 IP for general counsel (publish)4-28-16 IP for general counsel (publish)
4-28-16 IP for general counsel (publish)Stephen Mason
 
Conjoint survey paper
Conjoint survey paperConjoint survey paper
Conjoint survey paperJaeWon Lee
 

Similar to Epip 2013 (20)

Client advisory faq patents - 2011
Client advisory   faq patents - 2011Client advisory   faq patents - 2011
Client advisory faq patents - 2011
 
Patent Quality Isn't the Question. Patent Value Is the Question.
Patent Quality Isn't the Question. Patent Value Is the Question.Patent Quality Isn't the Question. Patent Value Is the Question.
Patent Quality Isn't the Question. Patent Value Is the Question.
 
Methods to improve Freedom to Operate analysis
Methods to improve Freedom to Operate analysisMethods to improve Freedom to Operate analysis
Methods to improve Freedom to Operate analysis
 
Patent hold up and the antitrustization of frand - A multi-sided reappraisal ...
Patent hold up and the antitrustization of frand - A multi-sided reappraisal ...Patent hold up and the antitrustization of frand - A multi-sided reappraisal ...
Patent hold up and the antitrustization of frand - A multi-sided reappraisal ...
 
What every Tech Startup should know about Intellectual Property
What every Tech Startup should know about Intellectual PropertyWhat every Tech Startup should know about Intellectual Property
What every Tech Startup should know about Intellectual Property
 
Understanding the Financial Value of Your Patent Portfolio: A Practical Guide...
Understanding the Financial Value of Your Patent Portfolio: A Practical Guide...Understanding the Financial Value of Your Patent Portfolio: A Practical Guide...
Understanding the Financial Value of Your Patent Portfolio: A Practical Guide...
 
You Need Defensive Patents but You Don't Have Any. Now What? A Case Study
You Need Defensive Patents but You Don't Have Any. Now What? A Case StudyYou Need Defensive Patents but You Don't Have Any. Now What? A Case Study
You Need Defensive Patents but You Don't Have Any. Now What? A Case Study
 
Bidding the Inventions as Incentive Schemes and the Ownership Structure
Bidding the Inventions as Incentive Schemes and the Ownership StructureBidding the Inventions as Incentive Schemes and the Ownership Structure
Bidding the Inventions as Incentive Schemes and the Ownership Structure
 
Patent Portfolio Development and Use
Patent Portfolio Development and UsePatent Portfolio Development and Use
Patent Portfolio Development and Use
 
mHealth Israel_Patent Strategy: Disruptive vs Incremental Innovation
mHealth Israel_Patent Strategy: Disruptive vs  Incremental InnovationmHealth Israel_Patent Strategy: Disruptive vs  Incremental Innovation
mHealth Israel_Patent Strategy: Disruptive vs Incremental Innovation
 
IP presentation_impact_hub_final-22
IP presentation_impact_hub_final-22IP presentation_impact_hub_final-22
IP presentation_impact_hub_final-22
 
Management Of Technology(Ravish Roshan,9968009808)
Management Of Technology(Ravish Roshan,9968009808)Management Of Technology(Ravish Roshan,9968009808)
Management Of Technology(Ravish Roshan,9968009808)
 
Profiting from technological innovation
Profiting from technological innovationProfiting from technological innovation
Profiting from technological innovation
 
Patent Strategy for Startups, Hardware Workshop SF 2015
Patent Strategy for Startups, Hardware Workshop SF 2015 Patent Strategy for Startups, Hardware Workshop SF 2015
Patent Strategy for Startups, Hardware Workshop SF 2015
 
Patent thickets
Patent thicketsPatent thickets
Patent thickets
 
Standard Essential Patents Licensing Royalty Disputes 4Q 2013
Standard Essential Patents Licensing Royalty Disputes 4Q 2013Standard Essential Patents Licensing Royalty Disputes 4Q 2013
Standard Essential Patents Licensing Royalty Disputes 4Q 2013
 
How to choose between patents or trade secrets.pdf
How to choose between patents or trade secrets.pdfHow to choose between patents or trade secrets.pdf
How to choose between patents or trade secrets.pdf
 
4-28-16 IP for general counsel (publish)
4-28-16 IP for general counsel (publish)4-28-16 IP for general counsel (publish)
4-28-16 IP for general counsel (publish)
 
Market for technology
Market for technologyMarket for technology
Market for technology
 
Conjoint survey paper
Conjoint survey paperConjoint survey paper
Conjoint survey paper
 

Epip 2013

  • 1. A. Panagopoulos & Park 2013 1 Patents v. Trade Secrets In-Uck Park Andreas Panagopoulos
  • 2. Panagopoulos & Park 2013 2 Objective • Are patents better than TS and in what context? • This is important because recent theoretical evidence points to TS being conducive to tech transfer; see Anton and Yao 1993, and Henry and Ponce 2011 (both relying on a free riding threat).
  • 3. We argue that • patents have forward looking effects that TS lack • because they, can be used as bargaining chips in future tech transferring negotiations. • when patent rights are fully transferred they should merit a markup over TS. Panagopoulos & Park 2013 3
  • 4. In detail • It is understood that patent portfolios endow firms with the legal power needed in gaining a better hand in out of court settlement negotiations. In this respect, a transfer of patent rights that increases the size of a patent portfolio serves a dual purpose. Panagopoulos & Park 2013 4
  • 5. Dual purpose • A) It expands the firm’s tech-horizon, • B) It increases its legal gravity when bargaining an out of court settlement. • This suggests that a patent does not only convey monopoly profits on the technology embodied in the patent (as TS do), it also conveys pecuniary benefits that are related to the ability of a patent to be used as a bargaining chip for future licensing negotiations (markup).Panagopoulos & Park 2013 5
  • 6. Forms of tech transfer • From all different forms of tech transfer, such as licensing, the formation of a patent pool, patent donations, the sale of patents, or a firm takeover, only the last two imply a full transfer of patent rights that can merit such a markup. Panagopoulos & Park 2013 6
  • 7. Problem • Easy to argue, hard to prove because this argument implies that patents can capture rents from future deals. Hence the argument is recursive and if, at any point in a series of tech transferring agreements, a patent fails to capture sufficient rents (as to stimulate a patent generating innovation) the argument collapses. Panagopoulos & Park 2013 7
  • 8. Startups • We argue our case for a subset of all firms (albeit a very important one) startups. • This is because a) startup firms rely on tech transfer and b) they lack the funds and legal power to avoid being coerced into a deal by an incumbent who holds a patent portfolio and alleges infringement, and c) a series of startup buyouts is now a familiar occurrence (OI). Panagopoulos & Park 2013 8
  • 9. Asymmetries • In strengthening our argument, we argue our case in the most favorable scenario for TS i.e. TS fully avoid disclosing the technology at hand. Hence TS cannot invite infringement proceedings, patents can. • i.e. two asymmetries: startups are different than incumbents; TS avoid disclosure, while patents don’t. Panagopoulos & Park 2013 9
  • 10. The model • We analyze a model in which an incumbent who owns a patent portfolio negotiates (via Nash bargaining) a takeover agreement with a sequence of startups. With each takeover the patent portfolio of the incumbent increases, increasing i) her ability to threaten future startups with infringement proceedings and ii) her bargaining power in future takeover negotiations. Panagopoulos & Park 2013 10
  • 11. Results: • We find that as long as IP protection is moderate patents can motivate R&D efforts that would not have taken place otherwise. If IP protection is balanced startups should prefer TS Panagopoulos & Park 2013 11
  • 12. Panagopoulos & Park 2013 12 Why balanced? • If IP protection is limited entrants abstain from innovating; because their innovation is not adequately protected from the incumbent. • The same holds true if IP protection is very strong. • If IP protection is moderate, the incumbent’s benefits of a takeover go beyond commercializing the new innovation.
  • 13. Panagopoulos & Park 2013 13 A static model • Firm 1 is the dominant firm, and 2 is the startup. • Firm 2 can do R&D at a cost C>0. • The value of the innovation is V>0 if 2 commercialises it, and if firm 1 does as well (Note: is not the driving force behind our results) • Innovation is sequential; potential infringement. • If the case ends in court 2 loses with probability p. • No litigation cost. VV * VV *
  • 14. Panagopoulos & Park 2013 14 • The disagreement/threat points of the firm are the respective expected surpluses from litigation. 2211 , * 2121 * 2 * 1 21 max :Hence , :asdefinedissetbargainingNashthe gy,technolotheofvaluemaximumtheisSince 1and dsds VssssB V VpdpVd Bss
  • 15. Panagopoulos & Park 2013 15 • Stronger IP protection (a greater p) decreases the share of 2 via weakening its bargaining position, reducing her incentives to innovate. • Note: this is also a licensing solution. • A takeover/licensing is always preferable to litigation. 1,0/ 2 11 )( 2 11 )( * * 2 * 1 VVr V rrp ps V rrp ps
  • 16. For TS Panagopoulos & Park 2013 16 Vdd 21 and0 2 2 * 2 * 1 VV s VV s
  • 17. For the static model Since we have a one off Nash bargaining negotiation and there are no future benefits for patents: TS is better than patents because they do not invite infringement allegations. Panagopoulos & Park 2013 17
  • 18. Panagopoulos & Park 2013 18 A sequential model • With a positive level of IP protection the value of owning the PATENTED innovation to firm 1 is V* plus the increment in future bargaining share due to strengthening its bargaining position via enlarging its portfolio. • Therefore the surplus of firm 2 may be larger than in the static model. • To capture this we model probability p as a function of the number of patents in the incumbent’s portfolio t (where t also denotes time periods), and the level of IP protection z. ∂p/∂z>0, ∂p/∂t>0, ∂²p/∂t²<0
  • 19. Panagopoulos & Park 2013 19 • Patented innovation should stop when • What matters here though is if innovation via patents is possible when the cost of innovation is at least equal to the innovator’s payoff when the innovation is protected via a TS. • To display our point C is at least equal to 2’s maximum payoff from keeping the innovation as a TS. Hence, after this point is reached a TS prevails i.e. firms prefer the static solution. • We label the last period a startup innovates and patents as T. Cts2
  • 20. • Nonetheless, not all startups are created as equal. • Some have an R&D cost above C, some not (skewed distribution). • We assume that is the probability that the R&D cost is zero, and (1- ) that it is greater or equal to C. Panagopoulos & Park 2013 20
  • 21. Panagopoulos & Park 2013 21 Notation • X(t): the value of the incumbent from deals surrounding innovations not yet realised, at the beginning of a period with portfolio t • s1 and s2 the bargaining shares, from Nash bargaining, of the two firms (incumbent and entrant). • discount rate • If the case is litigated the incumbent wins with probability p(z), where z denotes IP protection.
  • 22. Panagopoulos & Park 2013 22 The model • On the last date T that there is a patented innovation: • NOTE: the hat above a variable denotes t<=T (1),)1()(ˆ)(ˆ 1 TXTsTX
  • 23. Panagopoulos & Park 2013 23 • On the first date that there is no innovation by a high cost firm: (2),)1()()(1)( 1 tXtstXtX
  • 24. Panagopoulos & Park 2013 24 )()1( * tXtXV VtpdVtpd zz )(1,)( 2 * 1 The total surplus that the innovation can generate to the two firms is maximised when firm 1 commercialises it and adds it to its patent portfolio. In this case the total surplus is: The threat points are
  • 25. Panagopoulos & Park 2013 25 The bargaining shares • Which can be plugged into eq. (2) to get a difference equation that describes X(1), X(2)….etc. • Note: s1 & s2 are strictly greater than the static licensing solution. 2 1 2 11 2 1 2 11 * 2 * 1 tXtX V rrtp ts tXtX V rrtp ts z z
  • 26. Panagopoulos & Park 2013 26 The difference equation * 3 11 3 12 1 V rrtp tXtXtX z Proposition: The above sequence {X(t)} is unique, monotonically increases at a decreasing rate, i.e., X(t)-X(t- 1)>X(t+1)-X(t)>0 for all t>1, and converges to * 12 11 V rrp X z Proposition: in any equilibrium there exists T<∞ such that a startup does not innovate and patent in any period t>T.
  • 27. Panagopoulos & Park 2013 27 Before reaching T )(ˆ)1( * tXtXV VtpdVtpd zz )(1,)( 2 * 1 The total surplus that the innovation can generate to the two firms is maximised when firm 1 commercialises it and adds it to its patent portfolio. In this case the total surplus is: The threat points are TsTs tXtX V rrtp ts tXtX V rrtp ts z z 22 * 2 * 1 ˆ 2 ˆ1 2 11 ˆ 2 ˆ1 2 11 ˆ
  • 28. Panagopoulos & Park 2013 28 TsCTs TsTs 22 22 ˆthatpossibleisit ˆAs We solve this problem through the use of mixed strategies. We show that there exists a unique value α∈(0,1-η), for which an equilibrium solution is possible.
  • 29. Panagopoulos & Park 2013 29 Theorem • Up to T high cost startups prefer patents after that startups are indifferent to patents or TS (TS prevails). • A similar argument is proved for low cost startups. • The argument does not collapse because: • Patent length • Patent donations
  • 30. Panagopoulos & Park 2013 30 Simulation We initially simulate for δ=.97 and η=.2 and then for δ=.99 and η=.8. To provide an example (in line with the magnitudes of z we find): when z=.007 a firm with a portfolio made up of 100 patents stands a 50% chance of winning its case, and an increase of 1 patent raises this by .34%. We argue our case for V*=1, r=1, and C=1.0001. An r=1 allows for results that are not driven by the disparity between V and V*, Additionally, by choosing C>1 we ensure that: a) innovation by high-cost startups may only be possible in a dynamic model b) that IP protection is necessary for such innovation because pz(t) is constant at 0 for all t if z=0, erasing any dynamic effect. t z ztp 11)(
  • 31. Panagopoulos & Park 2013 31 Converging s2
  • 32. Panagopoulos & Park 2013 32 Inverse U • To examine how z affects T, we find the values of T for z's between .0001 and .01 in 20 steps of .0005.
  • 33. Panagopoulos & Park 2013 33 Varying δ
  • 34. Panagopoulos & Park 2013 34 Varying η